Home > Healthcare > Medical Devices > Therapeutic Devices > Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market Trends

Report ID: GMI2998
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Continuous Renal Replacement Therapy Market Trends

The significant improvements in user interface, automation, and safety characteristics of continuous renal replacement treatment systems will have positive impact on the market growth. Touch-screen interfaces, automatic changes depending on patient characteristics, and safety alerts have become standard features in newer CRRT machines, making them easier to use while lowering the chances of treatment mistakes. Moreover, healthcare facilities are rapidly adopting these solutions as they make the preparation procedure easier, provide regular fluid balance during treatment, and lower the chance of mistakes when producing replacement fluids. For instance, in January 2023, Peconic Bay Medical Centre announced the launch of a new and advanced dialysis program, CRRT, to be offered to patients suffering from kidney damages.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Continuous renal replacement therapy industry size was over USD 1 billion in 2022 and is projected to expand at 6.9% CAGR from 2023 to 2032, driven by the increasing prevalence of chronic renal diseases globally.

The consumables segment is estimated to reach USD 1.3 billion by 2032 owing to the widespread adoption of high-performance hemofilters and dialyzers.

North America continuous renal replacement therapy industry size exceeded USD 371 million in 2022 and will record substantial growth through 2032 attributed to the high demand for CRRT from the expanding senior population prone to renal failure.

Some of the major companies engaged in the continuous renal replacement therapy industry are Medtronic, B.Braun Melsungen, Asahi Kasei Corporation, Baxter International Inc., Medica, Medites, Medical Components, Nikkiso, Nxtstage, Toray, and Tricol Biomedical.